Welcome to Dividends Inside
Welcome to Dividends Inside!

The platform is currently in beta, so some features and data may still change as we improve the service. If you have questions, feedback, or run into anything unexpected, please contact us at info@dividendsinside.com.

Intuitive Surgical, Inc.

ISRG
$441.58 (- $0.28 - 0.06%)
Last updated: Previous Close (2026-05-19)
ISRG Metrics
Exchange
🇺🇸 NASDAQ XNGS
Nasdaq/NGS (Global Select Market)United StatesAmerica/New_York
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINUS46120E6023
Market Price441.58
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E Ratio52.53
EPS7.87
Market Cap$185.8B
Book Value47.7
Price to Book12.099
Beta-0.16
52w High603.88
52w Low417.74
Next Earnings DateN/A
About the Company
Intuitive Surgical, Inc. is a global technology leader in minimally invasive care, specializing in robotic-assisted surgical systems. The company develops and provides advanced da Vinci surgical platforms that enable physicians to perform complex procedures with enhanced precision, control, and visualization, supporting specialties such as urology, gynecology, general surgery, colorectal, thoracic, cardiac, bariatric, head and neck. Its offerings extend to digital solutions, bronchoscopy systems, and data analytics tools that optimize care delivery, improve outcomes, enhance care team and patient experiences, and promote lower costs and broader access. Intuitive Surgical, Inc. collaborates closely with healthcare professionals worldwide to advance less invasive treatments across various procedures. Founded in 1995 and headquartered in Sunnyvale, California, the company plays a pivotal role in transforming surgical practices through innovative technology that prioritizes patient safety, product reliability, and expanded care accessibility.
Price History
Latest News for ISRG
Intuitive Surgical Has Dropped 20% This Year. Wall Street Says It's Time to Buy.
Intuitive Surgical is in its own bear market, which has historically been a good time for aggressive growth investors to buy.
Can ISRG's da Vinci 5 Momentum Sustain Procedure and Utilization Gains?
ISRG's da Vinci 5 is driving stronger utilization and procedure growth, but can higher throughput and after-hours surgeries sustain momentum?
Intuitive Surgical (ISRG) Is Among The Best Agentic AI Stocks To Buy Right Now
With an upside potential of 35.5%, Intuitive Surgical, Inc. (NASDAQ:ISRG) remains a bullish pick among analysts. The stock, therefore, earns its place on our list of the best agentic AI stocks to buy right now. On April 21, 2026, Intuitive Surgical, Inc. (NASDAQ:ISRG) reported strong first-quarter results, exceeding Wall Street projections in both revenue and […]
Jim Cramer Discusses the Performance of Danaher and Its Peers
Danaher Corporation (NYSE:DHR) was one of the stocks on which Jim Cramer shared his take, explaining that dot-com analogies do not hold up in this market. Cramer called it a “one-time excellent company,” as he said: For instance, Danaher, another one-time excellent company, has seen the stock just get pulverized after not-so-great quarters, or I […]
Intuitive Surgical Trades Near 2-Year Low: Is $600 Within Reach?
ISRG nears a key support level after a 23.7% YTD drop, but strong da Vinci 5 adoption and procedure growth may fuel a rebound.
What Intuitive Surgical (ISRG)'s FDA Class I Recall and Institutional Selling Mean For Shareholders
In recent months, Intuitive Surgical has faced FDA Class I recalls on certain da Vinci stapler components and visible institutional selling, reflecting elevated concern around product safety and regulatory scrutiny despite earlier strong quarterly results. These developments coincide with ongoing competition in surgical robotics and highlight how regulatory risk and large investor behavior can quickly influence perceptions of an otherwise growing, cash-generative business model. We’ll now...